Early-Onset Myopia Intervention Project

NARecruitingINTERVENTIONAL
Enrollment

508

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

May 31, 2028

Conditions
MyopiaPre-myopia
Interventions
DRUG

0.01% atropine eye drops

Participants will use 0.01% atropine eyedrops nightly for myopia control.

DRUG

0.05% atropine eye drops

Participants will use 0.05% atropine eyedrops nightly for myopia control.

DEVICE

Spectacle lenses with highly aspherical lenslets

"These are a special type of eyeglass lenses designed primarily to slow down the progression of myopia (nearsightedness) in children. The center of the lens provides a clear correction for distance vision, just like regular glasses. The surrounding area contains hundreds of tiny, invisible, and highly aspherical (complex curved) microlenses. These microlenses create a special optical effect. While the child looks straight ahead clearly, peripheral light rays are focused in front of the retina. This is called myopic defocus. Research suggests that this myopic defocus signal helps to control the excessive elongation of the eyeball, which is the main cause of myopia getting worse."

Trial Locations (1)

Unknown

RECRUITING

Shanghai Eye Disease Prevention and Treatment Center, Shanghai

All Listed Sponsors
lead

Shanghai Eye Disease Prevention and Treatment Center

OTHER